Initial and mid-term results of sirolimus-eluting stent implantation in acute coronary syndrome: A comparison with bare metal stenting

Japanese Journal of Interventional Cardiology

Volumn 22, Issue 3, 2007, Pages 219-223

  Okada, Hisayuki ^a   Mutou, Makoto ^a   Hasuda, Toshio ^a   Ishikawa, Tetsuya ^a   Tajima, Osamu ^a   Imai, Kamon ^a  

^a Saitama Cardiovascular and Respiratory Center ^*  (Japan)

Author keywords

ACS; DES; PCI

Indexed keywords

RAPAMYCIN;

ACUTE CORONARY SYNDROME; ARTICLE; BARE METAL STENT; DRUG ELUTING STENT; HUMAN; IMPLANTATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; RESTENOSIS; SAFETY; STENT; THROMBOSIS; TREATMENT OUTCOME;

EID: 34347364715     PISSN: 09148922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Sousa JE, et al : Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries : A quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 103 : 192-195, 2001.
2. Morice MC, et al : A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 : 1773-1180, 2002.
3. Leon MB, et al : A multicenter randomized clinical study of the sirolimus-eluting stent in native coronary lesions : Angiographic results. Circulation 106 : 11-393, 2002.
4. Moussa I, et al : Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. Circulation 99 : 2364-2366, 1999.
5. Bertrand ME, et al : Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : The clopidogrel aspirin stent international cooperation study (CLASSICS) . Circulation 102 : 624629, 2000.
6. Gaku N, et al : Clinical and angiographic outcomes of sirolimus-eluting stents implantation in Japanese patients in daily practice. Circ J 70 : 136771, 2006.
7. Colombo A, et al : Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 109 : 1244-1249, 2004.
8. Park SJ, et al : Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis : Comparison with bare metal stent implantation. J Am Coll Cardiol 45 : 351-356, 2005.
9. Ardissino D, et al : Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries : A randomized trial. JAMA 292 : 2727-2734, 2004.
10. Ge L, et al : Treatment of saphenous vein graft lesions with drug-eluting stents : Immediate and midterm outcome. J Am Coll Cardiol 45 : 989994, 2005.
11. Gouchi T, et al : Promising efficacy of the sirolimus-eluting stent in patients with acute myocardial infarction. J Cardiol 48 : 253-261, 2006.
12. Lemos PA, et al : Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes : Insights from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. J Am Coll Cardiol 41 : 2093-2099, 2003.
13. Cheneau E, et al : Impact of sirolimus-eluting stents on outcomes of patients treated for acute myocardial infarction by primary angioplasty. Catheter Cardiovasc Interv 65 : 469-472, 2005.
14. Park CB, et al : Safety and efficacy with drug-eluting stent in ST-segment elevation and non-ST-segment elevation myocardial infarction. Clin Cardiol 29 : 199-203, 2006.
15. Newell MC, et al : Comparison of safety and efficacy of sirolimus-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction. Am J Cardiol 97 : 1299-1302, 2006.
16. Park DW, et al : Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol 98 : 352-356, 2006.
17. Ong AT, et al : Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after baremetal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 45 : 947-953, 2005.
18. Iakovou I, et al : Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 : 2126-2130, 2005.
19. Kernis SJ, et al : The incidence, predictors, and outcomes of early reinfarction after primary angioplasty for myocardial infarction. J Am Coll Cardiol 42 : 1173-1177, 2003.
20. Wu C, et al : A risk score to predict in-hospital mortality for percutaneous coronary interventions. J Am Coll Cardiol 47 : 654-660, 2006.
21. Lemos PA, et al : Shortand long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction. J Am Coll Cardiol 43 : 704-708, 2004.
22. Stabile E, et al : Late thrombosis in Cypher stents after the discontinuation of antiplatelet therapy. Cardiovasc Radiat Med 5 : 173-176, 2004.
23. Kuchulakanti PK, et al : Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus-and paclitaxel-eluting stents. Circulation 113 : 1108-1113, 2006.
24. Ong AT, et al : Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 45 : 2088-2092, 2005.
25. Nasser M, et al : Late thrombosis of sirolimus-eluting stents following noncardiac surgery. Catheter Cardiovasc Interv 65 : 516-519, 2005.
26. Waters RE, et al : Late thrombosis following treatment of in-stent restenosis with drug-eluting stents after discontinuation of antiplatelet therapy. Catheter Cardiovasc Interv 65 : 520-524, 2005.